2 Peninsula biotechs — including one led by Gilead's former top scientist — map out IPOs
Cancer-fighting Kronos and Spruce, targeting a serious hormonal condition, have a common investor in Omega Funds.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Health Management | Hormones | Pharmaceuticals